SRx Health Solutions Signed a Letter of Intent to Acquire the Assets of Royal Uranium

Rhea-AI Summary

SRx Health Solutions (NYSE American: SRXH) has signed a non-binding Letter of Intent to acquire 100% of Royal Uranium's assets, a uranium royalty business with an extensive portfolio across multiple countries. The acquisition includes 18 uranium royalties across exploration and development projects in Canada, Colombia, Argentina, and Namibia.

The strategic move aligns with increasing demand for nuclear energy, particularly driven by AI and data center power requirements. The company plans to rebrand with a new name and ticker symbol to reflect its focus on energy royalties. Key partnerships include major uranium operators like Cameco, UEC, Denison Mines, and ISO Energy. Global data center power consumption is projected to surge 160% by 2030, with AI-related demand expected to add 200 TWh annually.

Positive

• Portfolio of 18 uranium royalties across strategic locations in Americas
• Partnerships with major uranium operators including Cameco, UEC, and Denison Mines
• Strategic positioning for AI and data center power demand growth
• Exposure to uranium market with projected significant growth potential

Negative

• Non-binding Letter of Intent subject to definitive agreements
• Acquisition still requires customary closing conditions
• Company rebranding may create temporary market confusion
• Significant dependence on uranium market performance

News Market Reaction

-16.02%

13 alerts

-16.02% News Effect

-13.0% Trough in 29 hr 57 min

-$1M Valuation Impact

$6M Market Cap

0.1x Rel. Volume

On the day this news was published, SRXH declined 16.02%, reflecting a significant negative market reaction. Argus tracked a trough of -13.0% from its starting point during tracking. Our momentum scanner triggered 13 alerts that day, indicating notable trading interest and price volatility. This price movement removed approximately $1M from the company's valuation, bringing the market cap to $6M at that time.

Data tracked by StockTitan Argus on the day of publication.

TAMPA, Fla., Aug. 18, 2025 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE American: SRXH) (“SRx Health” or the “Company”), a leading global health and wellness company, today announced that is has signed a non-binding Letter of Intent to purchase 100% of the assets of Royal Uranium Inc., a leading uranium royalty business with a portfolio spanning Canada, Colombia, Argentina and Namibia.

The acquisition is subject to customary closing conditions, including the negotiation and execution of definitive transaction agreements.

Following the closing of this potential transaction, the Company intends to adopt a new corporate name and new ticker symbol, reflecting its expanded mission to combine hard-asset energy royalties to capitalize on surging AI & data center power demand.

Positioned for the Future of Energy
The acquisition would deliver a diversified portfolio of 18 uranium royalties across premier exploration and development projects in the Americas, providing long-term leverage to a commodity at the center of the global clean energy transition. Key royalties include:

1. 1.0% NSR on the Berlin Project in Colombia
2. 2.0% NSR on Mountain Lake in Canada
3. 1.0% NSR on non-Mountain Lake properties in Nunavut
4. 2.0% NSR on Laguna Salada in Argentina
5. 1.0% NSR on Huemul in Argentina
6. 2.0% NSR on Anna Lake & B Zone in Canada
7. 2.0% NSR on Larocque Lake in Canada
8. 2.0% NSR on Bell Lake in Canada
9. 2.0% NSR on Flat Rock Island in Canada
10. 2.0% NSR on Shea Creek in Canada
11. 2.0% NSR on Shasko Bay in Canada
12. 2.0% NSR on Pine South Channel in Canada
13. 2.0% NSR on PLS Regional in Canada
14. 2.0% NSR on Kelic Lake in Canada
15. 2.0% NSR on Cable Bay (Ursa) in Canada
16. 2.0% NSR on Virgin River
17. 2.0% NSR on Lazy Edward Bay in Canada
18. 2.0% NSR on Perpete Lake in Canada

These royalties represent a diversified exposure to uranium development projects across key jurisdictions in North and rest of world, offering long-term upside potential as the global demand for nuclear energy and uranium increases. Partners on these royalties include world class uranium operators such as Cameco, UEC, Denison Mines, ISO Energy, and others.

Tapping Into Surging AI & Data Center Power Demand
Nuclear energy with its 24/7 baseload power and near-zero carbon emissions is increasingly being adopted by major tech companies to secure reliable power for AI operations. Royal Uranium’s strategy is to capitalize on the remarkable growth in energy demand from AI and hyperscale data centers by building royalty portfolio which offers highly strategic exposure to a tightening market with multi-decade growth potential. Global data center power consumption is forecast to increase by more than 160% by 2030, with AI-related demand alone projected to add 200 TWh annually by the end of the decade.

About SRx Health Solutions, Inc.
SRx Health Solutions Inc. is an integrated Canadian healthcare services provider that operates within the specialty healthcare industry. The SRx network extends across all ten Canadian provinces, making it one of the most accessible providers of comprehensive, integrated, and customized specialty healthcare services in the country. SRx combines years of industry knowledge, technology, and patient-centric focus to create strategies and solutions that consistently exceed client expectations and drive critical patient care initiatives aimed to improve the wellness of Canadians. For more information on SRx Health Solutions Inc., please visit www.srxhealth.com.

Forward Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The words “believe,” “may,” “estimate,” “continue,” “anticipate,” “intend,” “should,” “plan,” “could,” “target,” “potential,” “is likely,” “will,” “expect” and similar expressions, as they relate to us, are intended to identify forward-looking statements. The Company has based these forward-looking statements largely on our current expectations and projections about future events and financial trends that we believe may affect our financial condition, results of operations, business strategy and financial needs. Some or all of the results anticipated by these forward-looking statements may not be achieved. Further information on the Company’s risk factors is contained in our filings with the SEC. Any forward-looking statement made by us herein speaks only as of the date on which it is made. Factors or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them. The Company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by law.

Company Contact:
SRx Health Solutions, Inc.
Kent Cunningham, Chief Executive Officer

Investor Contact:
KCSA Strategic Communications
Valter Pinto, Managing Director
T: 212-896-1254
Valter@KCSA.com

FAQ

What assets is SRx Health Solutions (SRXH) acquiring from Royal Uranium?

SRx Health Solutions is acquiring 18 uranium royalties across exploration and development projects in Canada, Colombia, Argentina, and Namibia, including various NSR (Net Smelter Return) royalties ranging from 1.0% to 2.0%.

How does the Royal Uranium acquisition align with AI and data center growth?

The acquisition positions SRXH to capitalize on increasing energy demand from AI and data centers, with global data center power consumption expected to grow 160% by 2030 and AI-related demand adding 200 TWh annually.

What are the key royalty assets included in SRXH's potential acquisition?

Key royalties include 1.0% NSR on the Berlin Project in Colombia, 2.0% NSR on Mountain Lake in Canada, and multiple 2.0% NSR royalties on various Canadian properties including Shea Creek, Virgin River, and Lazy Edward Bay.

Who are the major uranium operators partnered with the Royal Uranium assets?

The royalty portfolio includes partnerships with world-class uranium operators such as Cameco, UEC, Denison Mines, and ISO Energy.

What are the conditions for completing the SRXH-Royal Uranium deal?

The acquisition is subject to customary closing conditions, including the negotiation and execution of definitive transaction agreements. The current agreement is a non-binding Letter of Intent.